Previous work identified CD14+HLA-DRlo/neg monocytes as a predictor of poor prognosis and powerful mediators of immune suppression in GBM [8], NHL [9], chronic lymphocytic leukemia [18] melanoma [19], and renal cell cancer [20]. The gene discussed is CD14; the disease is B-cell chronic lymphocytic leukemia.